Kadimastem Financial Overview
Kadimastem's market cap is currently 161.06M. The company's EPS TTM is -2.308; its P/E ratio is -1.97; Kadimastem is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.